Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
42.01 (1y: +10%)
Market Cap 6 B P/E(ttm) 18.40
Enterprise Value 7.51 B P/B 2.70
XRAY- NAS (USA)
DENTSPLY International, Inc.
  • Currently 3.5/5
Business Predictability Rank: 3.5-Star
Back Testing Results:
Average gain of all 3.5-Star stocks: 9.3% per year.
% of Stocks that are in still loss if held for 10yrs: 9%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$42.01
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry		 vs
history
Cash to Debt 0.053
XRAY's Cash to Debt is ranked lower than
91% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.43 vs. XRAY: 0.053 )
XRAY' s 10-Year Cash to Debt Range
Min: 0.03   Max: 0.96
Current: 0.05
0.03
0.96
Equity to Asset -0.168
XRAY's Equity to Asset is ranked lower than
94% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.47 vs. XRAY: -0.168 )
XRAY' s 10-Year Equity to Asset Range
Min: -0.24   Max: 0.2
Current: -0.17
-0.24
0.2
Interest Coverage 7.9
XRAY's Interest Coverage is ranked lower than
66% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 46.10 vs. XRAY: 7.9 )
XRAY' s 10-Year Interest Coverage Range
Min: 8   Max: No Debt
Current: 7.9
F-Score: 6
Z-Score: 3.06
M-Score: -2.66
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating margin (%) 13.00
XRAY's Operating margin (%) is ranked higher than
65% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. XRAY: 13.00 )
XRAY' s 10-Year Operating margin (%) Range
Min: 4.3   Max: 18.4
Current: 13
4.3
18.4
Net-margin (%) 10.7
XRAY's Net-margin (%) is ranked higher than
68% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.30 vs. XRAY: 10.7 )
XRAY' s 10-Year Net-margin (%) Range
Min: 2.6   Max: 14.9
Current: 10.7
2.6
14.9
ROE (%) 14.2
XRAY's ROE (%) is ranked higher than
73% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. XRAY: 14.2 )
XRAY' s 10-Year ROE (%) Range
Min: 3.7   Max: 19.9
Current: 14.2
3.7
19.9
ROA (%) 6.3
XRAY's ROA (%) is ranked higher than
60% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. XRAY: 6.3 )
XRAY' s 10-Year ROA (%) Range
Min: 1.9   Max: 11.7
Current: 6.3
1.9
11.7
ROC (Joel Greenblatt) (%) 37.60
XRAY's ROC (Joel Greenblatt) (%) is ranked higher than
68% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.00 vs. XRAY: 37.60 )
XRAY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 12.5   Max: 54.9
Current: 37.6
12.5
54.9
Revenue Growth (%) 9
XRAY's Revenue Growth (%) is ranked higher than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. XRAY: 9 )
XRAY' s 10-Year Revenue Growth (%) Range
Min: 2.9   Max: 16
Current: 9
2.9
16
EBITDA Growth (%) 4.6
XRAY's EBITDA Growth (%) is ranked higher than
65% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. XRAY: 4.6 )
XRAY' s 10-Year EBITDA Growth (%) Range
Min: -20.3   Max: 39.5
Current: 4.6
-20.3
39.5
EPS Growth (%) 4.5
XRAY's EPS Growth (%) is ranked higher than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.15 vs. XRAY: 4.5 )
XRAY' s 10-Year EPS Growth (%) Range
Min: -25.8   Max: 60.8
Current: 4.5
-25.8
60.8
» XRAY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

XRAY Guru Trades in Q2 2012

Jim Simons 87,358 sh (New)
Steven Cohen 212,835 sh (New)
Columbia Wanger 1,649,500 sh (+37.17%)
John Keeley 41,490 sh (+0.12%)
Vanguard Health Care Fund 2,485,400 sh (unchged)
Tom Russo 1,000 sh (unchged)
Robert Olstein 162,000 sh (unchged)
Tom Gayner 35,400 sh (unchged)
Jeremy Grantham Sold Out
Meridian Funds 1,446,810 sh (-1.95%)
Mario Gabelli 242,940 sh (-3.34%)
Louis Moore Bacon 25,000 sh (-79.33%)
» More
Q3 2012

XRAY Guru Trades in Q3 2012

Steven Cohen 220,200 sh (+3.46%)
Meridian Funds 1,451,890 sh (+0.35%)
Columbia Wanger 1,649,500 sh (unchged)
Vanguard Health Care Fund 2,485,400 sh (unchged)
Robert Olstein 162,000 sh (unchged)
Tom Gayner 35,400 sh (unchged)
Jim Simons Sold Out
Louis Moore Bacon Sold Out
Tom Russo Sold Out
Mario Gabelli 239,240 sh (-1.52%)
John Keeley 36,790 sh (-11.33%)
» More
Q4 2012

XRAY Guru Trades in Q4 2012

Joel Greenblatt 24,660 sh (New)
Columbia Wanger 2,090,500 sh (+26.74%)
John Keeley 40,440 sh (+9.92%)
Tom Gayner 35,400 sh (unchged)
Robert Olstein 156,000 sh (-3.7%)
Vanguard Health Care Fund 2,285,400 sh (-8.05%)
Meridian Funds 1,288,000 sh (-11.29%)
Mario Gabelli 210,440 sh (-12.04%)
Steven Cohen 60,061 sh (-72.72%)
» More
Q1 2013

XRAY Guru Trades in Q1 2013

Jeremy Grantham 14,900 sh (New)
John Keeley 40,510 sh (+0.17%)
Mario Gabelli 210,440 sh (unchged)
Vanguard Health Care Fund 2,285,400 sh (unchged)
Columbia Wanger 2,090,500 sh (unchged)
Tom Gayner Sold Out
Joel Greenblatt Sold Out
Robert Olstein 144,000 sh (-7.69%)
Meridian Funds 1,062,000 sh (-17.55%)
Steven Cohen 4,317 sh (-92.81%)
» More
» Details

Insider Trades

Latest Guru Trades with XRAY

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-03-31 Sold Out 0.06%$39.59 - $43.49 $ 42.312%0
Tom Gayner 2013-03-31 Sold Out 0.06%$39.59 - $43.49 $ 42.312%0
Joel Greenblatt 2012-12-31 New Buy0.06%$36.17 - $40.5 $ 42.3110%24660
John Keeley 2012-03-31 Add 28.9%0.01%$35.02 - $40.19 $ 42.3118%41440
Ray Dalio 2011-12-31 Sold Out 0.25%$29.09 - $38.82 $ 42.3122%0
Jean-Marie Eveillard 2011-12-31 Sold Out 0.01%$29.09 - $38.82 $ 42.3122%0
Ray Dalio 2011-09-30 New Buy0.25%$30.86 - $39.555 $ 42.3120%550695
Meridian Funds 2011-09-30 Add 6.86%0.11%$30.86 - $39.555 $ 42.3120%1475476
Meridian Funds 2011-03-31 Add 19.38%0.24%$34.17 - $37.94 $ 42.3117%1309586
Ron Baron 2010-12-31 Sold Out 0.18%$30.86 - $34.79 $ 42.3131%0
Meridian Funds 2010-09-30 Add 15.64%0.21%$27.78 - $31.87 $ 42.3141%1211751
Meridian Funds 2010-06-30 Add 18.35%0.22%$30.08 - $37.96 $ 42.3126%1047851
John Keeley 2010-06-30 Reduce -27.8%0.01%$30.08 - $37.96 $ 42.3126%38020
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 18.40
XRAY's P/E(ttm) is ranked higher than
62% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.40 vs. XRAY: 18.40 )
XRAY' s 10-Year P/E(ttm) Range
Min: 12.2   Max: 114
Current: 18.4
12.2
114
P/B 2.70
XRAY's P/B is ranked lower than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. XRAY: 2.70 )
XRAY' s 10-Year P/B Range
Min: 2.08   Max: 5
Current: 2.7
2.08
5
P/S 2.10
XRAY's P/S is ranked higher than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. XRAY: 2.10 )
XRAY' s 10-Year P/S Range
Min: 1.58   Max: 3.59
Current: 2.1
1.58
3.59
PFCF 21.40
XRAY's PFCF is ranked higher than
57% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.35 vs. XRAY: 21.40 )
XRAY' s 10-Year PFCF Range
Min: 12.39   Max: 27.68
Current: 21.4
12.39
27.68
EV-to-EBIT 19.2
XRAY's EV-to-EBIT is ranked higher than
54% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.12 vs. XRAY: 19.2 )
XRAY' s 10-Year EV-to-EBIT Range
Min: 9.7   Max: 71.7
Current: 19.2
9.7
71.7
PEG 5.8
XRAY's PEG is ranked lower than
65% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. XRAY: 5.8 )
XRAY' s 10-Year PEG Range
Min: 0.52   Max: 558.6
Current: 5.8
0.52
558.6
Shiller P/E 21.3
XRAY's Shiller P/E is ranked higher than
79% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.85 vs. XRAY: 21.3 )
XRAY' s 10-Year Shiller P/E Range
Min: 15.92   Max: 37.32
Current: 21.3
15.92
37.32

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 0.50
XRAY's Dividend Yield is ranked higher than
61% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.55 vs. XRAY: 0.50 )
XRAY' s 10-Year Dividend Yield Range
Min: 0.35   Max: 0.95
Current: 0.5
0.35
0.95
Dividend Payout 0.0986
XRAY's Dividend Payout is ranked higher than
96% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.53 vs. XRAY: 0.0986 )
XRAY' s 10-Year Dividend Payout Range
Min: 0.07   Max: 0.45
Current: 0.1
0.07
0.45
Dividend growth (3y) 2.4
XRAY's Dividend growth (3y) is ranked higher than
90% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. XRAY: 2.4 )
XRAY' s 10-Year Dividend growth (3y) Range
Min: 2.4   Max: 10.9
Current: 2.4
2.4
10.9
Yield on cost (5-Year) 0.60
XRAY's Yield on cost (5-Year) is ranked higher than
63% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. XRAY: 0.60 )
XRAY' s 10-Year Yield on cost (5-Year) Range
Min: 0.42   Max: 1.14
Current: 0.6
0.42
1.14
Share Buyback Rate 1
XRAY's Share Buyback Rate is ranked higher than
91% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -1.70 vs. XRAY: 1 )
XRAY' s 10-Year Share Buyback Rate Range
Min: 1.6   Max: -0.9
Current: 1

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 11.7
XRAY's Price/Net Current Asset Value is ranked higher than
57% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.40 vs. XRAY: 11.7 )
XRAY' s 10-Year Price/Net Current Asset Value Range
Min: 10.4   Max: 19.7
Current: 11.7
10.4
19.7
Price/DCF (Projected) 1.2
XRAY's Price/DCF (Projected) is ranked higher than
79% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. XRAY: 1.2 )
XRAY' s 10-Year Price/DCF (Projected) Range
Min: 1.1   Max: 2.1
Current: 1.2
1.1
2.1
Price/Median PS Value 0.9
XRAY's Price/Median PS Value is ranked higher than
60% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.90 vs. XRAY: 0.9 )
XRAY' s 10-Year Price/Median PS Value Range
Min: 0.8   Max: 1.5
Current: 0.9
0.8
1.5
Earnings Yield (Greenblatt) 5.20
XRAY's Earnings Yield (Greenblatt) is ranked higher than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. XRAY: 5.20 )
XRAY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.4   Max: 10.3
Current: 5.2
1.4
10.3
Forward Rate of Return (Yacktman) 6.48
XRAY's Forward Rate of Return (Yacktman) is ranked higher than
81% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.11 vs. XRAY: 6.48 )
XRAY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -6.8   Max: 35.8
Current: 6.48
-6.8
35.8

Business Description

DENTSPLY International, Inc was incorporated in 1899 in Delaware. It is the designer, developer, manufacturer and marketer of a broad range of professional dental products, with a primary focus on dental consumable products, dental laboratory products and dental specialty products. The Company's worldwide headquarters and executive offices are located in York, Pennsylvania. DENTSPLY distributes approximately 56% of its dental products through domestic and foreign distributors, dealers and importers. However, certain highly technical products such as precious metal dental alloys, dental ceramics, crown and bridge porcelain products, endodontic instruments and materials, orthodontic appliances, implants, and bone substitute and grafting materials are sold directly to the dental laboratory or dental professionals in some markets. Although many of its sales are made to distributors, dealers and importers, DENTSPLY focuses its marketing efforts on the dentists, dental hygienists, dental assistants, dental laboratories and dental schools who are the end-users of its products.The Company believes that the market for its products will grow over the long-term based on the following factors: Increasing worldwide population, Growth of the population 65 or older - The percentage of the U.S., European, Japanese and other regions population over age 65 is expected to nearly double by the year 2030. In addition to having significant needs for dental care, the elderly are well positioned to pay for the required procedures since they control sizable amounts of discretionary income, Natural teeth are being retained longer - Individuals with natural teeth are much more likely to visit a dentist in a given year than those without any natural teeth remaining, The changing dental practice in North America and Western Europe - Dentistry in North America and Western Europe has been transformed from a profession primarily dealing with pain, infections and tooth decay to one with increased emphasis on preventive care and cosmetic dentistry, Per capita and discretionary incomes are increasing in emerging nations - As personal incomes continue to rise in the emerging nations of the Pacific Rim, CIS and Latin America, healthcare, including dental services, are a growing priority.The Company conducts its operations, both domestic and foreign, under highly competitive market conditions. Competition in the dental products industry is based primarily upon product performance, quality, safety and ease of use, as well as price, customer service, innovation and acceptance by professionals and technicians. DENTSPLY believes that its principal strengths include its well-established brand names, its reputation for high quality and innovative products, its commitment to customer satisfaction and support of the Company's products by dental professionals. Products manufactured by DENTSPLY are sold primarily under its own trademarks and trade names. DENTSPLY also owns and
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO
Traded in other countries:DY2.Germany
» More Articles for XRAY

Headlines

Articles On GuruFocus.com
12 Healthcare Dividend Stocks With Highest Short Float Ratio Jun 02 2012 
New Guru Added: Ray Dalio of Bridgewater Associates Dec 02 2011 
DENTSPLY International Inc. Reports Operating Results (10-K) Feb 18 2011 
Baron Funds Buys MCP, DEI, ISRG, TRGP, NYT, ARB, PLCM, Sells DLR, XRAY, BLUD, GET, WWE Feb 17 2011 
Meridian Fund Q3 Update; Buys CPWR, EBAY, MDT, MLHR, PPL Nov 10 2010 
Meridian Funds Buys Steelcase Inc., W.W. Grainger Inc., Monsanto Company, Sells Adobe Systems Inc., Aug 05 2010 
Align Technologies Takes One in the Teeth Apr 06 2010 
Tom Gayner Top Buys: ITC Holdings Corp., Patterson Companies Inc., Schlumberger Ltd., Walgreen Compa Nov 09 2009 
Markel Corp’s Tom Gayner Buys ITC Holdings Corp., Patterson Companies Inc., Pool Corp., Sells Gold Nov 06 2009 
Richard Aster Jr Buys Zebra Technologies Corp., Bunge Ltd., Liz Claiborne Inc., Sells Time Warner In Nov 03 2006 


Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial